2738877-91-1

Lp-PLA2-IN-4 Chemical Structure
2738877-91-1

Chemical Structure

Lp-PLA2-IN-4

  • CAS No.: 2738877-91-1
  • Formula:C23H18F5N3O4
  • Molecular Weight:495.40

IUPAC Name: (5R)-10-((3,5-difluoro-4-(3-(trifluoromethyl)phenoxy)benzyl)oxy)-2,3,5,6-tetrahydro-8H-1,5-methanopyrimido[1,6-d][1,4,6]oxadiazocin-8-one

InChIKey: WQTLAEMFJNYZHB-MRXNPFEDSA-N

SMILES: O=C1N2C(N3C[C@@H](OCC3)C2)=CC(OCC4=CC(F)=C(C(F)=C4)OC5=CC(C(F)(F)F)=CC=C5)=N1

Biological Activity: Lp-PLA2-IN-4 is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2). Lp-PLA2 previously known as platelet- activating factor acetylhydrolase (PAF-AH), is a phospholipase A2 enzyme involved in hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2-IN-4 has the potential for the research of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease (extracted from patent WO2021228159A1, compound 38)[1].

Cat. No. Product Name Purity Description Pricing
HY-142669
Lp-PLA2-IN-4 Lp-PLA2-IN-4 is a potent inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2). Lp-PLA2 previously known as platelet- activating factor acetylhydrolase (PAF-AH), is a phospholipase A2 enzyme involved in hydrolysis of lipoprotein lipids or phospholipids. Lp-PLA2-IN-4 has the potential for the research of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease (extracted from patent WO2021228159A1, compound 38).
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)
Amount: USD 0.00

This product is a controlled substance and not for sale in your territory.

Pricing 
Expand Hide
References